Impact of Rotavac Vaccine on Hospital-Based Disease Prevalence and Strain Diversity in India: A Systematic Review and Meta-Analysis
- PMID: 40776477
- DOI: 10.1002/rmv.70066
Impact of Rotavac Vaccine on Hospital-Based Disease Prevalence and Strain Diversity in India: A Systematic Review and Meta-Analysis
Abstract
Rotavirus (RV) is a major aetiology of childhood gastroenteritis worldwide. It is crucial to understand the hospital-based RV disease prevalence and its spatio-temporal genotype distribution during the period pre-and post-introduction of RV vaccines in India. A systematic review and meta-analysis were performed to extract information on literature related to the impact of vaccination on rotavirus disease prevalence and the distribution of genotypes from 1986 to 2022. A search for relevant articles was carried out in public databases (PubMed, Google Scholar, and ScienceDirect) to extract specific information on RV prevalence among children less than 5 years of age and the genotype distribution from 1986 to 2022. DerSimonian-Laird random-effects model was employed to account for the heterogeneity of included studies analysed using meta-analysis and publication bias was assessed using funnel plot and Egger linear regression test. Of the 1939 records identified through screening and after removing duplicate records, the full texts of 1609 records were assessed for eligibility. After the full-text assessment, 49 records were found eligible and included in the study. The estimated pooled prevalence of RV-associated gastroenteritis during the pre-vaccine period was 33% {(95% confidence interval (CI), 28%-38%)} while the prevalence was 23% (95% CI, 18%-29%) in the post-vaccine period. Rotaviruses are classified into genotypes by their G-(glycoprotein VP7) and P-(protease-sensitive VP4) proteins. Combination of genotype G1 and P[8] that is G1P[8] predominated during the pre- and post-vaccine period, while the prevalence of G3P[8] increased after immunisation. The dominant genotypes in pre-vaccine era were G1 and G2 while G1 and G3 after vaccine inclusion, with a constant circulation of P[8] during the entire period from 1986 to 2022. Occurence of G2 increased post-vaccination in western zone of India. As observed from the meta-regression analysis, rotavirus vaccination has significantly reduced gastroenteritis associated hospitalizations and death. The spatio-temporal change in the genotype distribution in the post-vaccination era warrants the need for further surveillance studies to provide information on RV-associated hospital visits. Additionally, this will also provide information on detection of emerging strains that can assist in designing future policies for the implementation and development of new-generation vaccines against rotavirus disease.
Keywords: gastroenteritis; genotypes; prevalence; rotavirus; surveillance; vaccination.
© 2025 John Wiley & Sons Ltd.
Similar articles
-
Genetic Profile of Rotavirus Type A in Children under 5 Years Old in Africa: A Systematic Review of Prevalence.Viruses. 2024 Feb 3;16(2):243. doi: 10.3390/v16020243. Viruses. 2024. PMID: 38400019 Free PMC article.
-
A rotavirus VP4 or VP7 monoreassortant panel identifies genotypes that are less susceptible to neutralization by systemic antibodies induced by vaccination or natural infection.mBio. 2025 Jul 9;16(7):e0089725. doi: 10.1128/mbio.00897-25. Epub 2025 May 30. mBio. 2025. PMID: 40444468 Free PMC article.
-
Rotavirus trends and distribution of genotypes before and during COVID-19 pandemic era: Bangladesh, 2017-2021.J Med Virol. 2024 May;96(5):e29681. doi: 10.1002/jmv.29681. J Med Virol. 2024. PMID: 38773815
-
Prevalence, Pattern and Genetic Diversity of Rotaviruses among Children under 5 Years of Age with Acute Gastroenteritis in South Africa: A Systematic Review and Meta-Analysis.Viruses. 2021 Sep 23;13(10):1905. doi: 10.3390/v13101905. Viruses. 2021. PMID: 34696335 Free PMC article.
-
Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: insights for understanding the impact of rotavirus vaccination programs.Vaccine. 2012 Apr 27;30 Suppl 1:A122-30. doi: 10.1016/j.vaccine.2011.09.111. Vaccine. 2012. PMID: 22520121
References
-
- H. Wang, M. Naghavi, C. Allen, et al., “Global, Regional, and National Life Expectancy, All‐Cause Mortality, and Cause‐Specific Mortality for 249 Causes of Death, 1980–2015: A Systematic Analysis for the Global Burden of Disease Study 2015,” Lancet. 388, no. 10053 (2016): 1459–1544, https://doi.org/10.1016/s0140‐6736(16)31012‐1.
-
- R. Chilengi, K. Mwila‐Kazimbaya, M. Chirwa, et al., “Immunogenicity and Safety of Two Monovalent Rotavirus Vaccines, ROTAVAC® and ROTAVAC 5D® in Zambian Infants,” Vaccine 39, no. 27 (2021): 3633–3640, https://doi.org/10.1016/j.vaccine.2021.04.060.
-
- GBD Diarrhoeal Diseases Collaborators, M. Forouzanfar, P. C. Rao, et al., “Estimates of Global, Regional, and National Morbidity, Mortality, and Aetiologies of Diarrhoeal Diseases: A Systematic Analysis for the Global Burden of Disease Study 2015,” Lancet Infectious Diseases, [published correction appears in Lancet Infect Dis 2017 Sep; 17(9): 897] 17, no. 9 (2017): 909–948, https://doi.org/10.1016/s1473‐3099(17)30276‐1.
-
- U. D. Parashar, E. G. Hummelman, J. S. Bresee, M. A. Miller, and R. I. Glass, “Global Illness and Deaths Caused by Rotavirus Disease in Children,” Emerging Infectious Diseases 9, no. 5 (2003): 565–572.
-
- Rotavirus Classification Working Group. “List of Accepted Genotypes,” (2019). Accessed, April 2, 2019, https://rega.kuleuven.be/cev/viralmetagenomics/virus‐classification/newg....
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials